Achilles Therapeutics Plc Stock Alpha and Beta Analysis
| ACHL Stock | USD 1.43 0.01 0.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Achilles Therapeutics PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Achilles Therapeutics over a specified time horizon. Remember, high Achilles Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Achilles Therapeutics' market risk premium analysis include:
Beta 0.28 | Alpha 0.56 | Risk 3.62 | Sharpe Ratio 0.18 | Expected Return 0.66 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Achilles |
Achilles Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Achilles Therapeutics market risk premium is the additional return an investor will receive from holding Achilles Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Achilles Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Achilles Therapeutics' performance over market.| α | 0.56 | β | 0.28 |
Achilles Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Achilles Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Achilles Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Achilles Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Achilles Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Achilles Therapeutics shares will generate the highest return on investment. By understating and applying Achilles Therapeutics stock market price indicators, traders can identify Achilles Therapeutics position entry and exit signals to maximize returns.
Achilles Therapeutics Return and Market Media
The median price of Achilles Therapeutics for the period between Mon, Dec 16, 2024 and Sun, Mar 16, 2025 is 1.17 with a coefficient of variation of 12.43. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 1.22, and mean deviation of 0.14. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Achilles Therapeutics Announces 12M AstraZeneca Deal, Plans Job Cuts | 12/24/2024 |
2 | 12 Health Care Stocks Moving In Tuesdays Pre-Market Session - Benzinga | 02/04/2025 |
3 | Achilles Therapeutics stock hits 52-week high at 1.41 - Investing.com | 03/13/2025 |
About Achilles Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Achilles or other stocks. Alpha measures the amount that position in Achilles Therapeutics PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | PB Ratio | 0.18 | 0.25 | 0.29 | Capex To Depreciation | 2.04 | 0.23 | 0.27 |
Achilles Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Achilles Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Achilles Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Achilles Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Achilles Therapeutics. Please utilize our Beneish M Score to check the likelihood of Achilles Therapeutics' management manipulating its earnings.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Achilles Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Achilles Therapeutics Backtesting, Achilles Therapeutics Valuation, Achilles Therapeutics Correlation, Achilles Therapeutics Hype Analysis, Achilles Therapeutics Volatility, Achilles Therapeutics History and analyze Achilles Therapeutics Performance. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Achilles Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.